Results 141 to 150 of about 832,143 (393)

A Feasibility Study of Patients with Major Depression and Substance Use Disorders: Vortioxetine as Maintenance Treatment

Neuropsychiatric Disease and Treatment, 2022
Ignacio Basurte-Villamor,1 Pablo Vega,2 Carlos Roncero,3– 5 José Martínez-Raga,6 Lara Grau-López,7– 10 Lourdes Aguilar,3– 5 Marta Torrens,11 Nestor Szerman12 1Department of Psychiatry and Behavioral Health, Clínica López Ibor, Madrid, Spain; 2Institute ...
Basurte-Villamor I, Vega P, Roncero C, Martínez-Raga J, Grau-López L, Aguilar L, Torrens M, Szerman N   +7 more
doaj  

Anxiety and autonomic regulation in major depressive disorder: an exploratory study [PDF]

, 1996
J.H.M. Tulen, Jan A. Bruijn, K.J. de Man, Eddy van der Velden, L. Pepplinkhuizen, Arie J. Manin t Veld   +5 more
openalex   +1 more source

GENETICS OF MAJOR DEPRESSIVE DISORDER

Bulletin of Problems Biology and Medicine, 2019
Major depressive disorder (MDD) is prevalent psychiatric disease with hereditary liability. It develops as a interaction result of genetic components and certain environmental factors. According to the results of the WHO investigation, the average global prevalence of major depressive disorder is 5%. There is a regional variation of this index, so that
O. I. Berezan, V. M. Pomohaibo, A. V. Petrushov   +2 more
openaire   +2 more sources

Nanomaterial‐Integrated Fiber Neural Probes for Deep Brain Monitoring and Modulation: Challenges and Opportunities

Advanced Functional Materials, EarlyView.
The article presents nanomaterial‐integrated fiber neural probes as innovative tools for deep brain molecular sensing, neural stimulation, and temperature monitoring. It examines breakthroughs in SERS‐based biomolecule detection, thermoplasmonic activation, and luminescent thermometry, alongside strategies to overcome stability, specificity, and ...
Di Zheng, Yang Li, Muhammad Fayyaz Kashif, Linda Piscopo, Massimo De Vittorio, Ferruccio Pisanello   +5 more
wiley   +1 more source

Optimal length of continuation therapy: A prospective assessment during fluoxetine long-term treatment of major depressive disorder [PDF]

, 1998
David Michelson, Michael G. Wilson, Kristina Sundell, Charles M. Beasley   +3 more
openalex   +1 more source

Possible association of Firmicutes in the gut microbiota of patients with major depressive disorder

Neuropsychiatric Disease and Treatment, 2018
Background Gut microbiota can affect human behavior and mood in many ways. Several studies have shown that patients with depression were also accompanied with gut microbiota disorder, in which Firmicutes are related to the protective function of ...
Yichen Huang, Xing Shi, Zhiyong Li, Yang Shen, Xinxin Shi, Liying Wang, Gaofei Li, Ye Yuan, Jixiang Wang, Yongchao Zhang, Lei Zhao, Meng Zhang, Yu Kang, Ying Liang   +13 more
semanticscholar   +1 more source

Miniaturized Wireless tDCS With Concentric Electrodes for Targeted Cortical Stimulation in Freely Moving Mice

Advanced Healthcare Materials, EarlyView.
This study introduces a wireless and miniaturized concentric‐electrode tDCS (CE‐tDCS) system tailored for freely moving mice. The device enables focal and multi‐site cortical stimulation via a lightweight, Bluetooth‐controlled platform. By integrating local neuromodulation with real‐time behavioral analysis, the system provides a robust tool for ...
Minseok Kim, Sehwan Park, Haeyun Lee, Giheon Kim, Namsun Chou, Hyogeun Shin   +5 more
wiley   +1 more source

Recognition and Treatment of Cognitive Dysfunction in Major Depressive Disorder

Frontiers in Psychiatry, 2018
Major Depressive Disorder (MDD) is a prevalent, chronic, disabling, and multidimensional mental disorder. Cognitive dysfunction represents a core diagnostic and symptomatic criterion of MDD, and is a principal determinant of functional non-recovery ...
Hannah Zuckerman, Z. Pan, Caroline Park, E. Brietzke, Natalie Musial, Aisha S. Shariq, M. Iacobucci, Samantha J. Yim, L. Lui, Carola Rong, R. McIntyre   +10 more
semanticscholar   +1 more source

Body Biofluids for Minimally‐Invasive Diagnostics: Insights, Challenges, Emerging Technologies, and Clinical Potential

Advanced Healthcare Materials, EarlyView.
Recent advances in diagnostics have accelerated the development of miniaturized wearable technologies for the continuous monitoring of diseases. This paradigm is shifting healthcare away from invasive, centralized blood tests toward decentralized monitoring, using alternative body biofluids.
Lanka Tata Rao, Chandan Kumar Mandal, Fernando Patolsky   +2 more
wiley   +1 more source

Efficacy of Org 3770 (mirtazapine) vs amitriptyline in patients with major depressive disorder: A meta-analysis [PDF]

, 1995
M. Zivkov, Kit C. B. Roes, Adri G. Pols
openalex   +1 more source